Dr. Donna Puleio
Overview
Donna V. Puleio, MD, FACP, is a medical oncologist at UPMC Hillman Cancer Center at UPMC Northwest.
Dr. Puleio is rated as an Experienced provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Chronic Myelogenous Leukemia (CML), and Philadelphia-Negative Chronic Myeloid Leukemia.
Her clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Fairfield Drive, Seneca, PA 16346
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center At UPMC Northwest
Shannon Penland, MD, MS, is a medical oncologist and treats all medical oncology and hematology patients. Dr. Penland is rated as a Distinguished provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). Her top areas of expertise are Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Familial Colorectal Cancer, and Lynch Syndrome.
Meadville Medical Center
Jennifer Orzano-Birgani is a Hematologist Oncology provider in Meadville, Pennsylvania. Dr. Orzano-Birgani is rated as an Advanced provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). Her top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Astrocytoma, and Non-Hodgkin Lymphoma.
Meadville Medical Center
Jason Brown is a Hematologist Oncology specialist and a Hematologist in Meadville, Pennsylvania. Dr. Brown is rated as a Distinguished provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Puleio isAdvanced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Puleio isAdvanced. Learn about Breast Cancer in Men.
- Chronic Myelogenous Leukemia (CML)
- Colorectal CancerDr. Puleio isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Puleio isAdvanced. Learn about Familial Colorectal Cancer.
- Lung CancerDr. Puleio isAdvanced. Learn about Lung Cancer.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Puleio isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Puleio isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Puleio isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Puleio isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.